MONTREAL--(BUSINESS WIRE)--Ability Biologics (“Ability” or “the company”) announced the closing of its $12 million (US) financing round led by founding investor Amplitude Ventures. Amplitude is joined ...
Molecular recognition and binding are fundamental to biological systems, which is exemplified by the specificity between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback